Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2024

Inhalt (20 Artikel)

Open Access Review

Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains

David Doubblestein, Linda Koehler, Elizabeth Anderson, Nicole Scheiman, Paula Stewart, Mark Schaverien, Jane Armer

Open Access Preclinical study

Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer

Henry G. Kaplan, Alexa K. Dowdell, Anna B. Berry, Racheli Ben Shimol, Fred L. Robinson, Christopher A. Carney, Brian D. Piening

Open Access Clinical trial

Comparison of long-term oncologic outcomes of central lumpectomy and conventional breast-conserving surgery for invasive breast cancer: propensity score matching analysis

Ji-Jung Jung, Jong-Ho Cheun, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Ki-Tae Hwang, Wonshik Han

Open Access Epidemiology

Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

Esmeralda Garcia-Torralba, Miguel Pérez Ramos, Alejandra Ivars Rubio, Esther Navarro Manzano, Noel Blaya Boluda, Miguel Lloret Gil, Alberto Aller, Pilar de la Morena Barrio, Elisa García Garre, Francisco Martínez Díaz, Francisco García Molina, Asunción Chaves Benito, Elena García-Martínez, Francisco Ayala de la Peña

Epidemiology

Infertility and risk of postmenopausal breast cancer in the women’s health initiative

Leslie V. Farland, Kimberly E. Lind, Cynthia A. Thomson, Nazmus Saquib, Aladdin H. Shadyab, Peter F. Schnatz, Rogelio Robles-Morales, Lihong Qi, Howard Strickler, Dorothy S. Lane, Gayathree Murugappan, Denise J. Roe, Holly R. Harris

Open Access Epidemiology

The distribution of breast density in women aged 18 years and older

Dilukshi Perera, Sarah Pirikahu, Jane Walter, Gemma Cadby, Ellie Darcey, Rachel Lloyd, Martha Hickey, Christobel Saunders, Michael Hackmann, David D. Sampson, John Shepherd, Lothar Lilge, Jennifer Stone

Epidemiology

Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992–2019

Nazanin Nasiri, Min Hu, Mohammad Hajizadeh

Original Laboratory Investigation

Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants

Hannah L. Chung, Lavinia P. Middleton, Jia Sun, Gary J. Whitman

Original Laboratory Investigation

Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases

Qi Wu, Sigrid Hatse, Cindy Kenis, Juan Fernández-García, Patricia Altea-Manzano, Jaak Billen, Mélanie Planque, Anke Vandekeere, Yentl Lambrechts, François Richard, Kevin Punie, Patrick Neven, Ann Smeets, Ines Nevelsteen, Giuseppe Floris, Christine Desmedt, Ana P. Gomes, Sarah-Maria Fendt, Hans Wildiers

Open Access Original Laboratory Investigation

Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies

Jesica M Godinez Paredes, Isabel Rodriguez, Megan Ren, Anali Orozco, Jeremy Ortiz, Anaseidy Albanez, Catherine Jones, Zeina Nahleh, Lilian Barreda, Lisa Garland, Edmundo Torres-Gonzalez, Dongjing Wu, Wen Luo, Jia Liu, Victor Argueta, Roberto Orozco, Eduardo Gharzouzi, Michael Dean

Research

Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade

Jorge Avila, Julieta Leone, Carlos T. Vallejo, Nancy U. Lin, José P. Leone

Research

Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab

María Gion, Juan José García-Mosquera, José Manuel Pérez-García, Vicente Peg, Manuel Ruiz-Borrego, Agostina Stradella, Begoña Bermejo, José Antonio Guerrero, Laura López-Montero, Mario Mancino, José Rodríguez-Morató, Gabriele Antonarelli, Miguel Sampayo-Cordero, Antonio Llombart-Cussac, Javier Cortés

Open Access Research

Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia

Lindsay J. Collin, Jade Jones, Rebecca Nash, Jeffrey M. Switchenko, Kevin C. Ward, Lauren E. McCullough

Open Access Research

The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study

Murad Guliyev, Gülin Alkan Şen, İlkay Gültürk, Nargiz Majidova, Goncagül Akdağ, Ali Ahadzade, Hande Turna, Nebi Serkan Demirci

Open Access Research

Ethnic inequities in use of breast conserving surgery and radiation therapy in Aotearoa/New Zealand: which factors contribute?

Leah Boyle, Ross Lawrenson, Vili Nosa, Ian Campbell, Sandar Tin Tin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.